Study: Methotrexate not fast enough against RA

New Zealand researchers say the way methotrexate currently is used to treat rheumatoid arthritis (RA) is not fast enough to control the onset of the joint damage caused by the disease. Scientists at the University of Otago Christchurch monitored the active forms of methotrexate in the blood cells of RA patients who were starting and stopping treatment with the drug. They found that it apparently takes much longer for methotrexate to reach steady blood levels than was previous thought. Investigators say their finding raises serious questions about the way doctors currently treat RA patients with the d